Au­robindo Phar­ma re­ceives warn­ing let­ter from In­di­a's SEC fol­low­ing more FDA ques­tion marks

In­di­an-based gener­ics man­u­fac­tur­er Au­robindo Phar­ma has been in the crosshairs of the FDA for sev­er­al years now, but the com­pa­ny is al­so at­tract­ing at­ten­tion from …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER